We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Malaria Biomarkers Detected In Human Breath

By LabMedica International staff writers
Posted on 13 Apr 2015
The majority of diagnoses of malaria rely on a combination of clinical presentation and visualizing parasites in a stained blood film or by performing a rapid diagnostic test.

Human breath offers an attractive alternative to blood as the basis for simple, non-invasive diagnosis of infectious disease, and when breath samples were taken during controlled human malaria infection specific malaria associated volatiles could be detected in human breath.

Scientists at the Commonwealth Scientific and Industrial Research Organization (CSIRO) (Dickson, Australia) and their colleagues collected breath samples from volunteers that had been infected with the malaria parasite Plasmodium falciparum, who were enrolled in a drug trial. More...
The volunteers breathed through a cardboard tube into a chamber connected to a connected to a 3‐L impermeable aluminum gas bag (Shanghai Sunrise Instrument Co.; Shanghai, China).

Exhaled breath analysis was carried out by gas chromatography-mass spectrometry. The gas chromatograph 451 Model GC (Bruker Daltonik Inc.; Billerica, MA, USA) was used and the Bruker Daltonik Scion SQ single quadrupole mass was set with a full scan detection. Real-time polymerase chain reactions and cell cultures were also performed.

The team identified nine compounds whose concentrations varied significantly over the course of malaria infection: carbon dioxide, isoprene, acetone, benzene, cyclohexanone and four thioethers. The latter group: allyl methyl sulfide, 1-methylthio-propane, (Z)-1-methylthio-1-propene and (E)-1-methylthio-1-propene had not previously been associated with any disease condition.

Before antimalarial-drug treatment, there was evidence of concurrent 48 hour-cyclical changes in both the levels of thioethers and parasitemia. Phase-shifting the values for thioether concentrations by 24 hours, revealed a direct correlation between the parasitemia and volatile levels. Volatile levels declined monotonically at around 6.5 hours after initial drug treatment, correlating with clearance of parasitemia. The study was published online on March 25, 2015, in the Journal of Infectious Diseases.

Related Links:
Commonwealth Scientific and Industrial Research Organization
Shanghai Sunrise Instrument Co.
Bruker Daltonik Inc.


Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Serological Pipet Controller
PIPETBOY GENIUS
New
Automated PCR Setup
ESTREAM
New
Candida Glabrata Test
ELIchrom Glabrata
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: The new study aims to enhance colorectal cancer prevention by identifying polyp molecular signals (Photo courtesy of Shutterstock)

RNA Screening Test Could Detect Colon Polyps Before They Become Cancerous

Colorectal cancer has become a growing health crisis, especially as it increasingly affects younger adults in their 20s, 30s, and 40s, while screening rates remain low. Colorectal cancer is now the leading... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: An “evolutionary” approach to treating metastatic breast cancer could allow therapy choices to be adapted as patients’ cancer changes (Photo courtesy of 123RF)

Evolutionary Clinical Trial to Identify Novel Biomarker-Driven Therapies for Metastatic Breast Cancer

Metastatic breast cancer, which occurs when cancer spreads from the breast to other parts of the body, is one of the most difficult cancers to treat. Nearly 90% of patients with metastatic cancer will... Read more

Pathology

view channel
Image: Micrograph showing the distribution of misfolded proteins in myeloma cells (Photo courtesy of Helmholtz Munich)

Novel Method Tracks Cancer Treatment in Cells Without Dyes or Labels

Multiple myeloma is a blood cancer that affects plasma cells in the bone marrow, leading to abnormal protein production, weakened immunity, and organ damage. Traditional methods for evaluating myeloma... Read more

Technology

view channel
Image: Researchers Dr. Lee Eun Sook and Dr. Lee Jinhyung examine the imprinting equipment used for nanodisk synthesis (Photo courtesy of KRISS)

Multifunctional Nanomaterial Simultaneously Performs Cancer Diagnosis, Treatment, and Immune Activation

Cancer treatments, including surgery, radiation therapy, and chemotherapy, have significant limitations. These treatments not only target cancerous areas but also damage healthy tissues, causing side effects... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.